Fluzopari Combined With Apatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer
Clinical trial NCT05597527 · UNKNOWN
Trial details
- NCT number
- NCT05597527
- Sponsor
- Fujian Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-01
- Primary completion
- 2025-05-31
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.